LATS2 and breast carcinoma: Indeed, genes commonly down-regulated in both Lats2-CKO PyMT tumors and LATS2L lumB human breast cancers were significantly enriched for “PPAR signaling” (Fig 5A), confirming the link between LATS2 and PPARγ activity in both mouse and human tumors.